PharmEasy, once valued at over $5 billion, seeks new funding at a 90% valuation cut Tech startup coverage that breaks down the funding, growth, and long-term trajectory of companies across every stage and industry, including climate, crypto, fintech, SaaS, transportation, and consumer tech.